Cargando…
Ivabradine Treatment in a Chronic Heart Failure Patient Cohort: Symptom Reduction and Improvement in Quality of Life in Clinical Practice
INTRODUCTION: In the prospective, open-label multicenter INTENSIFY study, the effectiveness and tolerability of ivabradine as well as its impact on quality of life (QOL) in chronic systolic heart failure (CHF) patients were evaluated over a 4-month period. METHODS: In CHF patients with an indication...
Autores principales: | Zugck, Christian, Martinka, Peter, Stöckl, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177104/ https://www.ncbi.nlm.nih.gov/pubmed/25160945 http://dx.doi.org/10.1007/s12325-014-0147-3 |
Ejemplares similares
-
Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016) -
Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011) -
Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
por: Rohm, Ilonka, et al.
Publicado: (2016) -
Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018) -
Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice
por: Perings, Stefan, et al.
Publicado: (2016)